Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Denosumab for the Prevention of Fragility Fractures in Hemodialysis: a Pilot Study for an Innovative, Randomized-controlled Trial, Embedded in Routine Care

NCT05096195 is registered in ClinicalTrials.gov with Western University, Canada as lead sponsor.

NCT NCT05096195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05096195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Denosumab for the Prevention of Fragility Fractures in Hemodialysis: a Pilot Study for an Innovative, Randomized-controlled Trial, Embedded in Routine Care
Lead sponsor
Western University, Canada
Phase
Phase 4
Overall status
Active, not recruiting
Start date
June 11, 2022
Completion date
December 31, 2025
Enrollment
60 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease-mineral and bone disorder, dialysis; complications, fragility fracture, kidney diseases